Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
68ga-nota-ae105 (1 trial)
Urinary Bladder Neoplasms (Phase 1)
Trials (1 total)
Trial APIs (1 total)